English

Arcadia Biosciences, Inc.

EDGAR

RKDA Quarterly report (10-Q) · filed 2026-08-13

Annual consolidated revenue for 2025: about USD 4.858M, using the latest reported figures. The previous period, 2024, was about USD 5.045M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

1.44 million USD

2026 Q2 · USD

Exact inputs and evidence

Revenue: 1443000 USD Source

Operating margin

-34.37%

2026 Q2 · %

Exact inputs and evidence

Operating Income: -496000 USD Source
Revenue: 1443000 USD Source

Operating cash flow

-300 thousand USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -1400000 USD Source
Operating Cash Flow: -1100000 USD Source

Cash and cash equivalents: 4.2 million USD 2026-06-30 Source
Exact value

4200000 USD
Long-term debt including current maturities: 114 thousand USD 2021-09-30 Source
Exact value

114000 USD
Shares outstanding: 2.18 million shares 2026-06-30 Source
Exact value

2181715 shares

Reported share-count change

59.59% · 815 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

1367040 shares · 2025-06-30· Source
2181715 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

4.75 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Revenue: 1302000 USD · 2025-07-01 – 2025-09-30 Source
Revenue: 4858000 USD · 2025-01-01 – 2025-12-31 Source
Revenue: 3957000 USD · 2025-01-01 – 2025-09-30 Source
Revenue: 1100000 USD · 2026-01-01 – 2026-03-31 Source
Revenue: 1443000 USD · 2026-04-01 – 2026-06-30 Source

Net income

-11.1 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Net income: 856000 USD · 2025-07-01 – 2025-09-30 Source
Net income: -2339000 USD · 2025-01-01 – 2025-12-31 Source
Net income: -1003000 USD · 2025-01-01 – 2025-09-30 Source
Net income: -4385000 USD · 2026-01-01 – 2026-03-31 Source
Net income: -6266000 USD · 2026-04-01 – 2026-06-30 Source

Operating cash flow

-2.48 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -3900000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -3621000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -4700000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -3900000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -1100000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -1400000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: -1100000 USD · 2026-01-01 – 2026-03-31 Source

Capital expenditure

0 USD

2025-01-01 – 2025-12-31

Exact inputs and evidence

Capital expenditure: 0 USD · 2025-01-01 – 2025-03-31 Source
Capital expenditure: 0 USD · 2025-01-01 – 2025-06-30 Source
Capital expenditure: 0 USD · 2025-01-01 – 2025-03-31 Source
Capital expenditure: 0 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 0 USD · 2025-01-01 – 2025-06-30 Source
Capital expenditure: 0 USD · 2025-01-01 – 2025-12-31 Source
Capital expenditure: 0 USD · 2025-01-01 – 2025-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-13.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2025-12-31
Operating income: 11 of 11 periods available· newest 2025-12-31
Net income: 11 of 11 periods available· newest 2025-12-31
Operating cash flow: 11 of 11 periods available· newest 2025-12-31
Capital expenditure: 11 of 11 periods available· newest 2025-12-31
Total assets: 11 of 11 periods available· newest 2025-12-31
Total liabilities: 11 of 11 periods available· newest 2025-12-31
Current assets: 11 of 11 periods available· newest 2025-12-31
Current liabilities: 11 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2025-12-31
Long-term debt including current maturities: 4 of 11 periods available· newest 2018-12-31
Shares outstanding: 11 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-3.7%

Prior period

USD 5.05 million

2024-01-01 – 2024-12-31
Current period

USD 4.86 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

4858000 − 5045000 = -187000 USD

5045000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
4858000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Arcadia Biosciences, Inc. · 2025-12-31 Arcadia Biosciences, Inc. (edgar:1469443) Year-over-year change in Revenue: -187000 USD Concept: fundies:Revenue Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T14:07:56Z Snapshot: 1b13331b9d503c7ea4550a045613fe3ca19abd69954e604f431ca88d32843666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1469443?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 4858000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000119312526126238/rkda-20251231.htm#2762419 Filing: 000119312526126238 Input fundies:Revenue: 5045000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000119312526126238/rkda-20251231.htm#2763841 Filing: 000119312526126238
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 4.7 million

Prior period

−USD 7.04 million

2024-01-01 – 2024-12-31
Current period

−USD 2.34 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-2339000 − -7038000 = 4699000 USD

-7038000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-2339000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Arcadia Biosciences, Inc. · 2025-12-31 Arcadia Biosciences, Inc. (edgar:1469443) Year-over-year change in Net income: 4699000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T14:07:56Z Snapshot: 1b13331b9d503c7ea4550a045613fe3ca19abd69954e604f431ca88d32843666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1469443?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -2339000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000119312526126238/rkda-20251231.htm#911318 Filing: 000119312526126238 Input fundies:NetIncome: -7038000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000119312526126238/rkda-20251231.htm#913183 Filing: 000119312526126238
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 4.9 million

Prior period

−USD 9.6 million

2024-01-01 – 2024-12-31
Current period

−USD 4.7 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-4700000 − -9600000 = 4900000 USD

-9600000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-4700000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Arcadia Biosciences, Inc. · 2025-12-31 Arcadia Biosciences, Inc. (edgar:1469443) Year-over-year change in Operating cash flow: 4900000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T14:07:56Z Snapshot: 1b13331b9d503c7ea4550a045613fe3ca19abd69954e604f431ca88d32843666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1469443?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -4700000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000119312526349205/rkda-20260630.htm#966639 Filing: 000119312526349205 Input fundies:OperatingCashFlow: -9600000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000119312526126238/rkda-20251231.htm#1333795 Filing: 000119312526126238
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-100%

Prior period

USD 16,000

2024-01-01 – 2024-12-31
Current period

USD 0

2025-01-01 – 2025-12-31

Exact inputs and evidence

0 − 16000 = -16000 USD

16000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
0 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Arcadia Biosciences, Inc. · 2025-12-31 Arcadia Biosciences, Inc. (edgar:1469443) Year-over-year change in Capital expenditure: -16000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T14:07:56Z Snapshot: 1b13331b9d503c7ea4550a045613fe3ca19abd69954e604f431ca88d32843666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1469443?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 0 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000119312526126238/rkda-20251231.htm#1254828 Filing: 000119312526126238 Input fundies:CapitalExpenditure: 16000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000119312526126238/rkda-20251231.htm#1256696 Filing: 000119312526126238
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

Revenue USD 4.86 million 100% of revenue
Operating costs Derived USD 7.36 million 151% of revenue
Operating income −USD 2.5 million −51% of revenue
Tax, interest and other Derived −USD 161,000 −3.3% of revenue
Net income −USD 2.34 million −48% of revenue

Cash

Operating cash flow −USD 4.7 million −97% of revenue
Capital expenditure USD 0 0% of revenue
Free cash flow Derived −USD 4.7 million −97% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2016 Operating loss: operating costs were 684% of revenue.
2017 Operating loss: operating costs were 456% of revenue.
2018 Operating loss: operating costs were 1,252% of revenue.
2019 Operating loss: operating costs were 1,758% of revenue.
2020 Operating loss: operating costs were 259% of revenue.
2021 Operating loss: operating costs were 624% of revenue.
2022 Operating loss: operating costs were 240% of revenue.
2023 Operating loss: operating costs were 237% of revenue.
2024 Operating loss: operating costs were 172% of revenue.
2025 Operating loss: operating costs were 151% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2016 2016-01-01 – 2016-12-31	3188000	21808000 Derived	-18620000	1004000 Derived	-19624000	-17286000 Derived	Source 2016-01-01 – 2016-12-31: 3188000 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -18620000 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -19624000 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -17055000 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 231000 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	4026000	18341000 Derived	-14315000	1392000 Derived	-15707000	-14044000 Derived	Source 2017-01-01 – 2017-12-31: 4026000 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -14315000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -15707000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -13965000 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 79000 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	1464000	18334000 Derived	-16870000	-3390000 Derived	-13480000	-13881000 Derived	Source 2018-01-01 – 2018-12-31: 1464000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -16870000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -13480000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -13631000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 250000 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	1169000	20550000 Derived	-19381000	9424000 Derived	-28805000	-18675000 Derived	Source 2019-01-01 – 2019-12-31: 1169000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -19381000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -28805000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -17198000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 1477000 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	8034000	20812000 Derived	-12778000	-8123000 Derived	-4655000	-32535000 Derived	Source 2020-01-01 – 2020-12-31: 8034000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -12778000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -4655000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -30200000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 2335000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	6780000	42306000 Derived	-35526000	-20866000 Derived	-14660000	-26907000 Derived	Source 2021-01-01 – 2021-12-31: 6780000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -35526000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -14660000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -25900000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 1007000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	4997000	11984000 Derived	-6987000	8389000 Derived	-15376000	-14072000 Derived	Source 2022-01-01 – 2022-12-31: 4997000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -6987000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -15376000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -14000000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 72000 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	4454000	10556000 Derived	-6102000	7879000 Derived	-13981000	-15305000 Derived	Source 2023-01-01 – 2023-12-31: 4454000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -6102000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -13981000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: -15300000 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 5000 USD Inspect Capital Expenditure Open source
2024 2024-01-01 – 2024-12-31	5045000	8693000 Derived	-3648000	3390000 Derived	-7038000	-9616000 Derived	Source 2024-01-01 – 2024-12-31: 5045000 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: -3648000 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: -7038000 USD Inspect Net Income Open source 2024-01-01 – 2024-12-31: -9600000 USD Inspect Operating Cash Flow Open source 2024-01-01 – 2024-12-31: 16000 USD Inspect Capital Expenditure Open source
2025 2025-01-01 – 2025-12-31	4858000	7358000 Derived	-2500000	-161000 Derived	-2339000	-4700000 Derived	Source 2025-01-01 – 2025-12-31: 4858000 USD Inspect Revenue Open source 2025-01-01 – 2025-12-31: -2500000 USD Inspect Operating Income Open source 2025-01-01 – 2025-12-31: -2339000 USD Inspect Net Income Open source 2025-01-01 – 2025-12-31: -4700000 USD Inspect Operating Cash Flow Open source 2025-01-01 – 2025-12-31: 0 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 4.9M 2025

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Revenue	3188000	Revenue: 3188000 Open source
20172017-12-31	Revenue	4026000	Revenue: 4026000 Open source
20182018-12-31	Revenue	1464000	Revenue: 1464000 Open source
20192019-12-31	Revenue	1169000	Revenue: 1169000 Open source
20202020-12-31	Revenue	8034000	Revenue: 8034000 Open source
20212021-12-31	Revenue	6780000	Revenue: 6780000 Open source
20222022-12-31	Revenue	4997000	Revenue: 4997000 Open source
20232023-12-31	Revenue	4454000	Revenue: 4454000 Open source
20242024-12-31	Revenue	5045000	Revenue: 5045000 Open source
20252025-12-31	Revenue	4858000	Revenue: 4858000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-3.7% 2025

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Year over year	-41.1%	Revenue: 3188000 Open source Revenue: 5414000 Open source
20172017-12-31	Year over year	26.3%	Revenue: 4026000 Open source Revenue: 3188000 Open source
20182018-12-31	Year over year	-63.6%	Revenue: 1464000 Open source Revenue: 4026000 Open source
20192019-12-31	Year over year	-20.2%	Revenue: 1169000 Open source Revenue: 1464000 Open source
20202020-12-31	Year over year	587.3%	Revenue: 8034000 Open source Revenue: 1169000 Open source
20212021-12-31	Year over year	-15.6%	Revenue: 6780000 Open source Revenue: 8034000 Open source
20222022-12-31	Year over year	-26.3%	Revenue: 4997000 Open source Revenue: 6780000 Open source
20232023-12-31	Year over year	-10.9%	Revenue: 4454000 Open source Revenue: 4997000 Open source
20242024-12-31	Year over year	13.3%	Revenue: 5045000 Open source Revenue: 4454000 Open source
20252025-12-31	Year over year	-3.7%	Revenue: 4858000 Open source Revenue: 5045000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -51.5% 2025

Net margin -48.1% 2025

Free cash flow margin -96.7% 2025

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Operating margin	-584.1%	Operating Income: -18620000 Open source Revenue: 3188000 Open source
20172017-12-31	Operating margin	-355.6%	Operating Income: -14315000 Open source Revenue: 4026000 Open source
20182018-12-31	Operating margin	-1,152.3%	Operating Income: -16870000 Open source Revenue: 1464000 Open source
20192019-12-31	Operating margin	-1,657.9%	Operating Income: -19381000 Open source Revenue: 1169000 Open source
20202020-12-31	Operating margin	-159%	Operating Income: -12778000 Open source Revenue: 8034000 Open source
20212021-12-31	Operating margin	-524%	Operating Income: -35526000 Open source Revenue: 6780000 Open source
20222022-12-31	Operating margin	-139.8%	Operating Income: -6987000 Open source Revenue: 4997000 Open source
20232023-12-31	Operating margin	-137%	Operating Income: -6102000 Open source Revenue: 4454000 Open source
20242024-12-31	Operating margin	-72.3%	Operating Income: -3648000 Open source Revenue: 5045000 Open source
20252025-12-31	Operating margin	-51.5%	Operating Income: -2500000 Open source Revenue: 4858000 Open source
20162016-12-31	Net margin	-615.6%	Net Income: -19624000 Open source Revenue: 3188000 Open source
20172017-12-31	Net margin	-390.1%	Net Income: -15707000 Open source Revenue: 4026000 Open source
20182018-12-31	Net margin	-920.8%	Net Income: -13480000 Open source Revenue: 1464000 Open source
20192019-12-31	Net margin	-2,464.1%	Net Income: -28805000 Open source Revenue: 1169000 Open source
20202020-12-31	Net margin	-57.9%	Net Income: -4655000 Open source Revenue: 8034000 Open source
20212021-12-31	Net margin	-216.2%	Net Income: -14660000 Open source Revenue: 6780000 Open source
20222022-12-31	Net margin	-307.7%	Net Income: -15376000 Open source Revenue: 4997000 Open source
20232023-12-31	Net margin	-313.9%	Net Income: -13981000 Open source Revenue: 4454000 Open source
20242024-12-31	Net margin	-139.5%	Net Income: -7038000 Open source Revenue: 5045000 Open source
20252025-12-31	Net margin	-48.1%	Net Income: -2339000 Open source Revenue: 4858000 Open source
20162016-12-31	Free cash flow margin	-542.2%	Revenue: 3188000 Open source Operating Cash Flow: -17055000 Open source Capital Expenditure: 231000 Open source
20172017-12-31	Free cash flow margin	-348.8%	Revenue: 4026000 Open source Operating Cash Flow: -13965000 Open source Capital Expenditure: 79000 Open source
20182018-12-31	Free cash flow margin	-948.2%	Revenue: 1464000 Open source Operating Cash Flow: -13631000 Open source Capital Expenditure: 250000 Open source
20192019-12-31	Free cash flow margin	-1,597.5%	Revenue: 1169000 Open source Operating Cash Flow: -17198000 Open source Capital Expenditure: 1477000 Open source
20202020-12-31	Free cash flow margin	-405%	Revenue: 8034000 Open source Operating Cash Flow: -30200000 Open source Capital Expenditure: 2335000 Open source
20212021-12-31	Free cash flow margin	-396.9%	Revenue: 6780000 Open source Operating Cash Flow: -25900000 Open source Capital Expenditure: 1007000 Open source
20222022-12-31	Free cash flow margin	-281.6%	Revenue: 4997000 Open source Operating Cash Flow: -14000000 Open source Capital Expenditure: 72000 Open source
20232023-12-31	Free cash flow margin	-343.6%	Revenue: 4454000 Open source Operating Cash Flow: -15300000 Open source Capital Expenditure: 5000 Open source
20242024-12-31	Free cash flow margin	-190.6%	Revenue: 5045000 Open source Operating Cash Flow: -9600000 Open source Capital Expenditure: 16000 Open source
20252025-12-31	Free cash flow margin	-96.7%	Revenue: 4858000 Open source Operating Cash Flow: -4700000 Open source Capital Expenditure: 0 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -4.7M 2025

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Operating cash flow	-17055000	Operating Cash Flow: -17055000 Open source
20172017-12-31	Operating cash flow	-13965000	Operating Cash Flow: -13965000 Open source
20182018-12-31	Operating cash flow	-13631000	Operating Cash Flow: -13631000 Open source
20192019-12-31	Operating cash flow	-17198000	Operating Cash Flow: -17198000 Open source
20202020-12-31	Operating cash flow	-30200000	Operating Cash Flow: -30200000 Open source
20212021-12-31	Operating cash flow	-25900000	Operating Cash Flow: -25900000 Open source
20222022-12-31	Operating cash flow	-14000000	Operating Cash Flow: -14000000 Open source
20232023-12-31	Operating cash flow	-15300000	Operating Cash Flow: -15300000 Open source
20242024-12-31	Operating cash flow	-9600000	Operating Cash Flow: -9600000 Open source
20252025-12-31	Operating cash flow	-4700000	Operating Cash Flow: -4700000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -4.7M 2025

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Free cash flow	-17286000	Operating Cash Flow: -17055000 Open source Capital Expenditure: 231000 Open source
20172017-12-31	Free cash flow	-14044000	Operating Cash Flow: -13965000 Open source Capital Expenditure: 79000 Open source
20182018-12-31	Free cash flow	-13881000	Operating Cash Flow: -13631000 Open source Capital Expenditure: 250000 Open source
20192019-12-31	Free cash flow	-18675000	Operating Cash Flow: -17198000 Open source Capital Expenditure: 1477000 Open source
20202020-12-31	Free cash flow	-32535000	Operating Cash Flow: -30200000 Open source Capital Expenditure: 2335000 Open source
20212021-12-31	Free cash flow	-26907000	Operating Cash Flow: -25900000 Open source Capital Expenditure: 1007000 Open source
20222022-12-31	Free cash flow	-14072000	Operating Cash Flow: -14000000 Open source Capital Expenditure: 72000 Open source
20232023-12-31	Free cash flow	-15305000	Operating Cash Flow: -15300000 Open source Capital Expenditure: 5000 Open source
20242024-12-31	Free cash flow	-9616000	Operating Cash Flow: -9600000 Open source Capital Expenditure: 16000 Open source
20252025-12-31	Free cash flow	-4700000	Operating Cash Flow: -4700000 Open source Capital Expenditure: 0 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

36.8% 2025

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Liabilities / assets	60.8%	Total Liabilities: 34376000 Open source Total Assets: 56574000 Open source
20172017-12-31	Liabilities / assets	51.7%	Total Liabilities: 8563000 Open source Total Assets: 16570000 Open source
20182018-12-31	Liabilities / assets	46.7%	Total Liabilities: 11209000 Open source Total Assets: 24024000 Open source
20192019-12-31	Liabilities / assets	74.4%	Total Liabilities: 24248000 Open source Total Assets: 32574000 Open source
20202020-12-31	Liabilities / assets	39.7%	Total Liabilities: 18796000 Open source Total Assets: 47348000 Open source
20212021-12-31	Liabilities / assets	29%	Total Liabilities: 12722000 Open source Total Assets: 43918000 Open source
20222022-12-31	Liabilities / assets	27.7%	Total Liabilities: 8022000 Open source Total Assets: 28922000 Open source
20232023-12-31	Liabilities / assets	35.5%	Total Liabilities: 7002000 Open source Total Assets: 19705000 Open source
20242024-12-31	Liabilities / assets	54%	Total Liabilities: 7294000 Open source Total Assets: 13517000 Open source
20252025-12-31	Liabilities / assets	36.8%	Total Liabilities: 2406000 Open source Total Assets: 6546000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

3.09× 2025

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Current assets / current liabilities	16.69×	Current Assets: 52222000 Open source Current Liabilities: 3129000 Open source
20172017-12-31	Current assets / current liabilities	4.27×	Current Assets: 15047000 Open source Current Liabilities: 3525000 Open source
20182018-12-31	Current assets / current liabilities	7.49×	Current Assets: 22876000 Open source Current Liabilities: 3054000 Open source
20192019-12-31	Current assets / current liabilities	4.98×	Current Assets: 28440000 Open source Current Liabilities: 5708000 Open source
20202020-12-31	Current assets / current liabilities	5.02×	Current Assets: 31696000 Open source Current Liabilities: 6314000 Open source
20212021-12-31	Current assets / current liabilities	7.02×	Current Assets: 35388000 Open source Current Liabilities: 5040000 Open source
20222022-12-31	Current assets / current liabilities	6.03×	Current Assets: 25398000 Open source Current Liabilities: 4209000 Open source
20232023-12-31	Current assets / current liabilities	4.17×	Current Assets: 14972000 Open source Current Liabilities: 3590000 Open source
20242024-12-31	Current assets / current liabilities	3.61×	Current Assets: 9242000 Open source Current Liabilities: 2563000 Open source
20252025-12-31	Current assets / current liabilities	3.09×	Current Assets: 6356000 Open source Current Liabilities: 2059000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2016 2016-01-01 – 2016-12-31	−USD 19.62 million Exact value Exact value: -19624000 USD 2016-01-01 – 2016-12-31: -19624000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Arcadia Biosciences, Inc. · 2016-12-31 Arcadia Biosciences, Inc. (edgar:1469443) Net Income: -19624000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T14:07:56Z Snapshot: 1b13331b9d503c7ea4550a045613fe3ca19abd69954e604f431ca88d32843666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1469443/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -19624000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000156459018006338/rkda-20171231.xml#120645 Filing: 000156459018006338 The citation records this snapshot. The page link may show a newer release later.	−USD 17.06 million Exact value Exact value: -17055000 USD 2016-01-01 – 2016-12-31: -17055000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Arcadia Biosciences, Inc. · 2016-12-31 Arcadia Biosciences, Inc. (edgar:1469443) Operating Cash Flow: -17055000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T14:07:56Z Snapshot: 1b13331b9d503c7ea4550a045613fe3ca19abd69954e604f431ca88d32843666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1469443/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -17055000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000156459018006338/rkda-20171231.xml#138007 Filing: 000156459018006338 The citation records this snapshot. The page link may show a newer release later.	USD 231,000 Exact value Exact value: 231000 USD 2016-01-01 – 2016-12-31: 231000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Arcadia Biosciences, Inc. · 2016-12-31 Arcadia Biosciences, Inc. (edgar:1469443) Capital Expenditure: 231000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T14:07:56Z Snapshot: 1b13331b9d503c7ea4550a045613fe3ca19abd69954e604f431ca88d32843666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1469443/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 231000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000156459018006338/rkda-20171231.xml#138676 Filing: 000156459018006338 The citation records this snapshot. The page link may show a newer release later.	−USD 17.29 million Calculation and evidence -17055000 − 231000 USD Exact free cash flow: -17286000 USD 2016-01-01 – 2016-12-31: -17055000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 231000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Arcadia Biosciences, Inc. · 2016-12-31 Arcadia Biosciences, Inc. (edgar:1469443) Free cash flow: -17286000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T14:07:56Z Snapshot: 1b13331b9d503c7ea4550a045613fe3ca19abd69954e604f431ca88d32843666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1469443?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -17055000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000156459018006338/rkda-20171231.xml#138007 Filing: 000156459018006338 Input fundies:CapitalExpenditure: 231000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000156459018006338/rkda-20171231.xml#138676 Filing: 000156459018006338 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 15.71 million Exact value Exact value: -15707000 USD 2017-01-01 – 2017-12-31: -15707000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Arcadia Biosciences, Inc. · 2017-12-31 Arcadia Biosciences, Inc. (edgar:1469443) Net Income: -15707000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T14:07:56Z Snapshot: 1b13331b9d503c7ea4550a045613fe3ca19abd69954e604f431ca88d32843666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1469443/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -15707000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000156459019010452/rkda-20181231.xml#165998 Filing: 000156459019010452 The citation records this snapshot. The page link may show a newer release later.	−USD 13.97 million Exact value Exact value: -13965000 USD 2017-01-01 – 2017-12-31: -13965000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Arcadia Biosciences, Inc. · 2017-12-31 Arcadia Biosciences, Inc. (edgar:1469443) Operating Cash Flow: -13965000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T14:07:56Z Snapshot: 1b13331b9d503c7ea4550a045613fe3ca19abd69954e604f431ca88d32843666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1469443/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13965000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000156459019010452/rkda-20181231.xml#189162 Filing: 000156459019010452 The citation records this snapshot. The page link may show a newer release later.	USD 79,000 Exact value Exact value: 79000 USD 2017-01-01 – 2017-12-31: 79000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Arcadia Biosciences, Inc. · 2017-12-31 Arcadia Biosciences, Inc. (edgar:1469443) Capital Expenditure: 79000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T14:07:56Z Snapshot: 1b13331b9d503c7ea4550a045613fe3ca19abd69954e604f431ca88d32843666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1469443/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 79000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000156459019010452/rkda-20181231.xml#190002 Filing: 000156459019010452 The citation records this snapshot. The page link may show a newer release later.	−USD 14.04 million Calculation and evidence -13965000 − 79000 USD Exact free cash flow: -14044000 USD 2017-01-01 – 2017-12-31: -13965000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 79000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Arcadia Biosciences, Inc. · 2017-12-31 Arcadia Biosciences, Inc. (edgar:1469443) Free cash flow: -14044000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T14:07:56Z Snapshot: 1b13331b9d503c7ea4550a045613fe3ca19abd69954e604f431ca88d32843666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1469443?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -13965000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000156459019010452/rkda-20181231.xml#189162 Filing: 000156459019010452 Input fundies:CapitalExpenditure: 79000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000156459019010452/rkda-20181231.xml#190002 Filing: 000156459019010452 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 13.48 million Exact value Exact value: -13480000 USD 2018-01-01 – 2018-12-31: -13480000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Arcadia Biosciences, Inc. · 2018-12-31 Arcadia Biosciences, Inc. (edgar:1469443) Net Income: -13480000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T14:07:56Z Snapshot: 1b13331b9d503c7ea4550a045613fe3ca19abd69954e604f431ca88d32843666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1469443/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -13480000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000156459020012875/rkda-20191231.xml#290078 Filing: 000156459020012875 The citation records this snapshot. The page link may show a newer release later.	−USD 13.63 million Exact value Exact value: -13631000 USD 2018-01-01 – 2018-12-31: -13631000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Arcadia Biosciences, Inc. · 2018-12-31 Arcadia Biosciences, Inc. (edgar:1469443) Operating Cash Flow: -13631000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T14:07:56Z Snapshot: 1b13331b9d503c7ea4550a045613fe3ca19abd69954e604f431ca88d32843666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1469443/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13631000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000156459020012875/rkda-20191231.xml#323414 Filing: 000156459020012875 The citation records this snapshot. The page link may show a newer release later.	USD 250,000 Exact value Exact value: 250000 USD 2018-01-01 – 2018-12-31: 250000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Arcadia Biosciences, Inc. · 2018-12-31 Arcadia Biosciences, Inc. (edgar:1469443) Capital Expenditure: 250000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T14:07:56Z Snapshot: 1b13331b9d503c7ea4550a045613fe3ca19abd69954e604f431ca88d32843666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1469443/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 250000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000156459020012875/rkda-20191231.xml#324256 Filing: 000156459020012875 The citation records this snapshot. The page link may show a newer release later.	−USD 13.88 million Calculation and evidence -13631000 − 250000 USD Exact free cash flow: -13881000 USD 2018-01-01 – 2018-12-31: -13631000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 250000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Arcadia Biosciences, Inc. · 2018-12-31 Arcadia Biosciences, Inc. (edgar:1469443) Free cash flow: -13881000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T14:07:56Z Snapshot: 1b13331b9d503c7ea4550a045613fe3ca19abd69954e604f431ca88d32843666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1469443?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -13631000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000156459020012875/rkda-20191231.xml#323414 Filing: 000156459020012875 Input fundies:CapitalExpenditure: 250000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000156459020012875/rkda-20191231.xml#324256 Filing: 000156459020012875 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 28.81 million Exact value Exact value: -28805000 USD 2019-01-01 – 2019-12-31: -28805000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Arcadia Biosciences, Inc. · 2019-12-31 Arcadia Biosciences, Inc. (edgar:1469443) Net Income: -28805000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T14:07:56Z Snapshot: 1b13331b9d503c7ea4550a045613fe3ca19abd69954e604f431ca88d32843666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1469443/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -28805000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000156459021017118/rkda-20201231.xml#333346 Filing: 000156459021017118 The citation records this snapshot. The page link may show a newer release later.	−USD 17.2 million Exact value Exact value: -17198000 USD 2019-01-01 – 2019-12-31: -17198000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Arcadia Biosciences, Inc. · 2019-12-31 Arcadia Biosciences, Inc. (edgar:1469443) Operating Cash Flow: -17198000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T14:07:56Z Snapshot: 1b13331b9d503c7ea4550a045613fe3ca19abd69954e604f431ca88d32843666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1469443/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -17198000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000156459021017118/rkda-20201231.xml#370863 Filing: 000156459021017118 The citation records this snapshot. The page link may show a newer release later.	USD 1.48 million Exact value Exact value: 1477000 USD 2019-01-01 – 2019-12-31: 1477000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Arcadia Biosciences, Inc. · 2019-12-31 Arcadia Biosciences, Inc. (edgar:1469443) Capital Expenditure: 1477000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T14:07:56Z Snapshot: 1b13331b9d503c7ea4550a045613fe3ca19abd69954e604f431ca88d32843666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1469443/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1477000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000156459021017118/rkda-20201231.xml#371704 Filing: 000156459021017118 The citation records this snapshot. The page link may show a newer release later.	−USD 18.68 million Calculation and evidence -17198000 − 1477000 USD Exact free cash flow: -18675000 USD 2019-01-01 – 2019-12-31: -17198000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 1477000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Arcadia Biosciences, Inc. · 2019-12-31 Arcadia Biosciences, Inc. (edgar:1469443) Free cash flow: -18675000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T14:07:56Z Snapshot: 1b13331b9d503c7ea4550a045613fe3ca19abd69954e604f431ca88d32843666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1469443?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -17198000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000156459021017118/rkda-20201231.xml#370863 Filing: 000156459021017118 Input fundies:CapitalExpenditure: 1477000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000156459021017118/rkda-20201231.xml#371704 Filing: 000156459021017118 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 4.66 million Exact value Exact value: -4655000 USD 2020-01-01 – 2020-12-31: -4655000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Arcadia Biosciences, Inc. · 2020-12-31 Arcadia Biosciences, Inc. (edgar:1469443) Net Income: -4655000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T14:07:56Z Snapshot: 1b13331b9d503c7ea4550a045613fe3ca19abd69954e604f431ca88d32843666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1469443/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -4655000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000095017022005253/rkda-20211231.htm#1084245 Filing: 000095017022005253 The citation records this snapshot. The page link may show a newer release later.	−USD 30.2 million Exact value Exact value: -30200000 USD 2020-01-01 – 2020-12-31: -30200000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Arcadia Biosciences, Inc. · 2020-12-31 Arcadia Biosciences, Inc. (edgar:1469443) Operating Cash Flow: -30200000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T14:07:56Z Snapshot: 1b13331b9d503c7ea4550a045613fe3ca19abd69954e604f431ca88d32843666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1469443/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -30200000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000095017022005253/rkda-20211231.htm#1805042 Filing: 000095017022005253 The citation records this snapshot. The page link may show a newer release later.	USD 2.34 million Exact value Exact value: 2335000 USD 2020-01-01 – 2020-12-31: 2335000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Arcadia Biosciences, Inc. · 2020-12-31 Arcadia Biosciences, Inc. (edgar:1469443) Capital Expenditure: 2335000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T14:07:56Z Snapshot: 1b13331b9d503c7ea4550a045613fe3ca19abd69954e604f431ca88d32843666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1469443/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2335000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000095017022005253/rkda-20211231.htm#1644211 Filing: 000095017022005253 The citation records this snapshot. The page link may show a newer release later.	−USD 32.54 million Calculation and evidence -30200000 − 2335000 USD Exact free cash flow: -32535000 USD 2020-01-01 – 2020-12-31: -30200000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 2335000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Arcadia Biosciences, Inc. · 2020-12-31 Arcadia Biosciences, Inc. (edgar:1469443) Free cash flow: -32535000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T14:07:56Z Snapshot: 1b13331b9d503c7ea4550a045613fe3ca19abd69954e604f431ca88d32843666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1469443?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -30200000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000095017022005253/rkda-20211231.htm#1805042 Filing: 000095017022005253 Input fundies:CapitalExpenditure: 2335000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000095017022005253/rkda-20211231.htm#1644211 Filing: 000095017022005253 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 14.66 million Exact value Exact value: -14660000 USD 2021-01-01 – 2021-12-31: -14660000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Arcadia Biosciences, Inc. · 2021-12-31 Arcadia Biosciences, Inc. (edgar:1469443) Net Income: -14660000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T14:07:56Z Snapshot: 1b13331b9d503c7ea4550a045613fe3ca19abd69954e604f431ca88d32843666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1469443/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -14660000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000095017023011019/rkda-20221231.htm#1228945 Filing: 000095017023011019 The citation records this snapshot. The page link may show a newer release later.	−USD 25.9 million Exact value Exact value: -25900000 USD 2021-01-01 – 2021-12-31: -25900000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Arcadia Biosciences, Inc. · 2021-12-31 Arcadia Biosciences, Inc. (edgar:1469443) Operating Cash Flow: -25900000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T14:07:56Z Snapshot: 1b13331b9d503c7ea4550a045613fe3ca19abd69954e604f431ca88d32843666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1469443/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -25900000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000095017023011019/rkda-20221231.htm#1816094 Filing: 000095017023011019 The citation records this snapshot. The page link may show a newer release later.	USD 1.01 million Exact value Exact value: 1007000 USD 2021-01-01 – 2021-12-31: 1007000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Arcadia Biosciences, Inc. · 2021-12-31 Arcadia Biosciences, Inc. (edgar:1469443) Capital Expenditure: 1007000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T14:07:56Z Snapshot: 1b13331b9d503c7ea4550a045613fe3ca19abd69954e604f431ca88d32843666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1469443/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1007000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000095017023011019/rkda-20221231.htm#1661179 Filing: 000095017023011019 The citation records this snapshot. The page link may show a newer release later.	−USD 26.91 million Calculation and evidence -25900000 − 1007000 USD Exact free cash flow: -26907000 USD 2021-01-01 – 2021-12-31: -25900000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 1007000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Arcadia Biosciences, Inc. · 2021-12-31 Arcadia Biosciences, Inc. (edgar:1469443) Free cash flow: -26907000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T14:07:56Z Snapshot: 1b13331b9d503c7ea4550a045613fe3ca19abd69954e604f431ca88d32843666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1469443?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -25900000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000095017023011019/rkda-20221231.htm#1816094 Filing: 000095017023011019 Input fundies:CapitalExpenditure: 1007000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000095017023011019/rkda-20221231.htm#1661179 Filing: 000095017023011019 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 15.38 million Exact value Exact value: -15376000 USD 2022-01-01 – 2022-12-31: -15376000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Arcadia Biosciences, Inc. · 2022-12-31 Arcadia Biosciences, Inc. (edgar:1469443) Net Income: -15376000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T14:07:56Z Snapshot: 1b13331b9d503c7ea4550a045613fe3ca19abd69954e604f431ca88d32843666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1469443/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -15376000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000095017025021203/rkda-20250214.htm#5690393 Filing: 000095017025021203 The citation records this snapshot. The page link may show a newer release later.	−USD 14 million Exact value Exact value: -14000000 USD 2022-01-01 – 2022-12-31: -14000000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Arcadia Biosciences, Inc. · 2022-12-31 Arcadia Biosciences, Inc. (edgar:1469443) Operating Cash Flow: -14000000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T14:07:56Z Snapshot: 1b13331b9d503c7ea4550a045613fe3ca19abd69954e604f431ca88d32843666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1469443/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -14000000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000095017025021203/rkda-20250214.htm#6177046 Filing: 000095017025021203 The citation records this snapshot. The page link may show a newer release later.	USD 72,000 Exact value Exact value: 72000 USD 2022-01-01 – 2022-12-31: 72000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Arcadia Biosciences, Inc. · 2022-12-31 Arcadia Biosciences, Inc. (edgar:1469443) Capital Expenditure: 72000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T14:07:56Z Snapshot: 1b13331b9d503c7ea4550a045613fe3ca19abd69954e604f431ca88d32843666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1469443/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 72000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000095017025021203/rkda-20250214.htm#6068228 Filing: 000095017025021203 The citation records this snapshot. The page link may show a newer release later.	−USD 14.07 million Calculation and evidence -14000000 − 72000 USD Exact free cash flow: -14072000 USD 2022-01-01 – 2022-12-31: -14000000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 72000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Arcadia Biosciences, Inc. · 2022-12-31 Arcadia Biosciences, Inc. (edgar:1469443) Free cash flow: -14072000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T14:07:56Z Snapshot: 1b13331b9d503c7ea4550a045613fe3ca19abd69954e604f431ca88d32843666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1469443?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -14000000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000095017025021203/rkda-20250214.htm#6177046 Filing: 000095017025021203 Input fundies:CapitalExpenditure: 72000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000095017025021203/rkda-20250214.htm#6068228 Filing: 000095017025021203 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 13.98 million Exact value Exact value: -13981000 USD 2023-01-01 – 2023-12-31: -13981000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Arcadia Biosciences, Inc. · 2023-12-31 Arcadia Biosciences, Inc. (edgar:1469443) Net Income: -13981000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T14:07:56Z Snapshot: 1b13331b9d503c7ea4550a045613fe3ca19abd69954e604f431ca88d32843666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1469443/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -13981000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000095017025044487/rkda-20241231.htm#987734 Filing: 000095017025044487 The citation records this snapshot. The page link may show a newer release later.	−USD 15.3 million Exact value Exact value: -15300000 USD 2023-01-01 – 2023-12-31: -15300000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Arcadia Biosciences, Inc. · 2023-12-31 Arcadia Biosciences, Inc. (edgar:1469443) Operating Cash Flow: -15300000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T14:07:56Z Snapshot: 1b13331b9d503c7ea4550a045613fe3ca19abd69954e604f431ca88d32843666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1469443/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -15300000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000095017025044487/rkda-20241231.htm#1445641 Filing: 000095017025044487 The citation records this snapshot. The page link may show a newer release later.	USD 5,000 Exact value Exact value: 5000 USD 2023-01-01 – 2023-12-31: 5000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Arcadia Biosciences, Inc. · 2023-12-31 Arcadia Biosciences, Inc. (edgar:1469443) Capital Expenditure: 5000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T14:07:56Z Snapshot: 1b13331b9d503c7ea4550a045613fe3ca19abd69954e604f431ca88d32843666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1469443/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000095017025044487/rkda-20241231.htm#1357857 Filing: 000095017025044487 The citation records this snapshot. The page link may show a newer release later.	−USD 15.31 million Calculation and evidence -15300000 − 5000 USD Exact free cash flow: -15305000 USD 2023-01-01 – 2023-12-31: -15300000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 5000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Arcadia Biosciences, Inc. · 2023-12-31 Arcadia Biosciences, Inc. (edgar:1469443) Free cash flow: -15305000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T14:07:56Z Snapshot: 1b13331b9d503c7ea4550a045613fe3ca19abd69954e604f431ca88d32843666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1469443?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -15300000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000095017025044487/rkda-20241231.htm#1445641 Filing: 000095017025044487 Input fundies:CapitalExpenditure: 5000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000095017025044487/rkda-20241231.htm#1357857 Filing: 000095017025044487 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 7.04 million Exact value Exact value: -7038000 USD 2024-01-01 – 2024-12-31: -7038000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Arcadia Biosciences, Inc. · 2024-12-31 Arcadia Biosciences, Inc. (edgar:1469443) Net Income: -7038000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T14:07:56Z Snapshot: 1b13331b9d503c7ea4550a045613fe3ca19abd69954e604f431ca88d32843666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1469443/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -7038000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000119312526126238/rkda-20251231.htm#913183 Filing: 000119312526126238 The citation records this snapshot. The page link may show a newer release later.	−USD 9.6 million Exact value Exact value: -9600000 USD 2024-01-01 – 2024-12-31: -9600000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Arcadia Biosciences, Inc. · 2024-12-31 Arcadia Biosciences, Inc. (edgar:1469443) Operating Cash Flow: -9600000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T14:07:56Z Snapshot: 1b13331b9d503c7ea4550a045613fe3ca19abd69954e604f431ca88d32843666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1469443/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9600000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000119312526126238/rkda-20251231.htm#1333795 Filing: 000119312526126238 The citation records this snapshot. The page link may show a newer release later.	USD 16,000 Exact value Exact value: 16000 USD 2024-01-01 – 2024-12-31: 16000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Arcadia Biosciences, Inc. · 2024-12-31 Arcadia Biosciences, Inc. (edgar:1469443) Capital Expenditure: 16000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T14:07:56Z Snapshot: 1b13331b9d503c7ea4550a045613fe3ca19abd69954e604f431ca88d32843666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1469443/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 16000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000119312526126238/rkda-20251231.htm#1256696 Filing: 000119312526126238 The citation records this snapshot. The page link may show a newer release later.	−USD 9.62 million Calculation and evidence -9600000 − 16000 USD Exact free cash flow: -9616000 USD 2024-01-01 – 2024-12-31: -9600000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 16000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Arcadia Biosciences, Inc. · 2024-12-31 Arcadia Biosciences, Inc. (edgar:1469443) Free cash flow: -9616000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T14:07:56Z Snapshot: 1b13331b9d503c7ea4550a045613fe3ca19abd69954e604f431ca88d32843666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1469443?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -9600000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000119312526126238/rkda-20251231.htm#1333795 Filing: 000119312526126238 Input fundies:CapitalExpenditure: 16000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000119312526126238/rkda-20251231.htm#1256696 Filing: 000119312526126238 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−USD 2.34 million Exact value Exact value: -2339000 USD 2025-01-01 – 2025-12-31: -2339000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Arcadia Biosciences, Inc. · 2025-12-31 Arcadia Biosciences, Inc. (edgar:1469443) Net Income: -2339000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T14:07:56Z Snapshot: 1b13331b9d503c7ea4550a045613fe3ca19abd69954e604f431ca88d32843666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1469443/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2339000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000119312526126238/rkda-20251231.htm#911318 Filing: 000119312526126238 The citation records this snapshot. The page link may show a newer release later.	−USD 4.7 million Exact value Exact value: -4700000 USD 2025-01-01 – 2025-12-31: -4700000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Arcadia Biosciences, Inc. · 2025-12-31 Arcadia Biosciences, Inc. (edgar:1469443) Operating Cash Flow: -4700000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T14:07:56Z Snapshot: 1b13331b9d503c7ea4550a045613fe3ca19abd69954e604f431ca88d32843666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1469443/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4700000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000119312526349205/rkda-20260630.htm#966639 Filing: 000119312526349205 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2025-01-01 – 2025-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Arcadia Biosciences, Inc. · 2025-12-31 Arcadia Biosciences, Inc. (edgar:1469443) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T14:07:56Z Snapshot: 1b13331b9d503c7ea4550a045613fe3ca19abd69954e604f431ca88d32843666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1469443/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000119312526126238/rkda-20251231.htm#1254828 Filing: 000119312526126238 The citation records this snapshot. The page link may show a newer release later.	−USD 4.7 million Calculation and evidence -4700000 − 0 USD Exact free cash flow: -4700000 USD 2025-01-01 – 2025-12-31: -4700000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Arcadia Biosciences, Inc. · 2025-12-31 Arcadia Biosciences, Inc. (edgar:1469443) Free cash flow: -4700000 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T14:07:56Z Snapshot: 1b13331b9d503c7ea4550a045613fe3ca19abd69954e604f431ca88d32843666 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1469443?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -4700000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000119312526349205/rkda-20260630.htm#966639 Filing: 000119312526349205 Input fundies:CapitalExpenditure: 0 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1469443/000119312526126238/rkda-20251231.htm#1254828 Filing: 000119312526126238 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

68 filings · 3,588 latest values · 3,588 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001469443, 1469443, RKDA, edgar:1469443

Also known as ARCADIA BIOSCIENCES, INC., Arcadia Biosciences, Inc., Arcadia Biosciences, Inc.

Arcadia Biosciences, Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2025 2025-01-01 – 2025-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation